TELA logo

TELA Bio (TELA) Company Overview

Profile

Full Name:

TELA Bio, Inc.

Sector:

Healthcare

Industry:

Medical Devices

Country:

United States

IPO:

November 8, 2019

Indexes:

Not included

Website:

http://www.telabio.com

Description:

TELA Bio is a medical technology company that develops and sells innovative surgical products. They focus on advanced materials for tissue repair and regeneration, helping surgeons improve patient outcomes. Their products are used in various surgical procedures, including hernia repair and orthopedic surgeries.

Key Details

Price

$2.52

Market Cap

$99.46 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$58.45 M(+41.13% YoY)

Annual EPS

-$2.04(+25.00% YoY)

PE Ratio

-

Annual ROE

-281.23%

Annual Debt To Equity

2.15

Beta

0.45

Events Calendar

Earnings

Next earnings date:

Mar 21, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Mar 21, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Nov 8, 24 Piper Sandler
Overweight
Oct 4, 24 Canaccord Genuity
Buy
Aug 13, 24 Piper Sandler
Overweight
Aug 13, 24 Lake Street
Buy
Aug 13, 24 JMP Securities
Market Outperform
Aug 13, 24 Canaccord Genuity
Buy
Jul 25, 24 Canaccord Genuity
Buy
May 10, 24 Piper Sandler
Overweight
Mar 22, 24 Piper Sandler
Overweight
Mar 22, 24 JMP Securities
Market Outperform

Screeners with TELA included

Growing Shares Outstanding
US stocks
Stocks below SMA 200
Most recommended stocks
Stocks below analysts price target
Healthcare sector
All stocks
Small cap stocks
Stocks with low beta
Medical Devices industry

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$2.52
TELA price is $2.52

Price All-time High

$22.61
TELA price is currently -88.83% below its historical high of $22.61

Price Analysts Target

$10.50
TELA price is currently -75.95% lower than the consensus analysts' forecast

Price Today Change

+0.2%
TELA price is up +0.2% today

Price YTD Change

-17.21%
TELA price is down -17.21% since January 1st

Price 3-Year Change

-80.29%
TELA price is down -80.29% over the past 3 years

Market cap

Market Cap

$99.46 M
TELA market capitalization is $99.46 million

Market Cap 3-Year Change

-46.56%
TELA market capitalization is down -46.56% over the past 3 years

Market Cap All-time High

$278.45 M
TELA market capitalization is currently -64.28% below its historical high of $278.45 million

Market Cap Sector Rank

46.51%
TELA market capitalization is higher than 46.51% of companies in Healthcare sector

Technical

Beta

0.45
TELA beta is 0.45

200-day SMA

$3.51
TELA price is currently -28.06% below its 200-day simple moving average

14-day RSI

39.47
TELA 14-day relative strength index is 39.47

30-day Relative Volume

1.02
TELA 30-day relative volume is 1.02

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$58.45 M
TELA annual revenue is $58.45 million

Annual Revenue Analysts Estimate

$74.72 M
TELA annual revenue is currently -21.77% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+41.13%
TELA annual revenue is up +41.13% year-on-year

Annual Revenue Sector Rank

49.77%
TELA annual revenue is higher than 49.77% of companies in Healthcare sector

Profit

Annual Gross Profit

$40.11 M
TELA annual gross profit is $40.11 million

Annual Gross Margin

68.62%
TELA annual gross profit margin is 68.62%

Annual Operating Profit

-$44.08 M
TELA annual operating income is -$44.08 million

Annual Operating Margin

-75.40%
TELA annual operating profit margin is -75.40%

Annual Net Income

-$46.66 M
TELA annual net profit is -$46.66 million

Annual Net Margin

-79.83%
TELA annual net profit margin is -79.83%

EPS

Annual EPS

-$2.04
TELA annual earnings per share is -$2.04

Annual EPS Analysts Estimate

-$1.44
TELA annual earnings per share is currently +42.16% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

+25%
TELA annual earnings per share is up +25% year-on-year

Annual EPS Sector Rank

41.73%
TELA annual earnings per share is higher than 41.73% of companies in Healthcare sector

ROA & ROE

Annual ROA

-63.97%
TELA annual return on assets is -63.97%

Annual ROE

-281.23%
TELA annual return on equity is -281.23%

EBIT & EBITDA

Annual EBIT

-$41.44 M
TELA annual earnings before interest & taxes is -$41.44 million

Annual EBITDA

-$40.63 M
TELA annual EBITDA is -$40.63 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
TELA price to earnings ratio value is unknown

PE Ratio Sector Rank

-
TELA price to earnings ratio is unknown

PB Ratio

PB Ratio

-15.86
TELA price to book ratio is -15.86

PB Ratio Sector Rank

2.07%
TELA price to book ratio is higher than 2.07% of companies in Healthcare sector

PS Ratio

PS Ratio

1.45
TELA price to sales ratio is 1.45

PS Ratio Sector Rank

32.77%
TELA price to sales ratio is higher than 32.77% of companies in Healthcare sector

Enterprise value

Enterprise Value

$123.68 M
TELA enterprise value is $123.68 million

Enterprise Value Sector Rank

50.59%
TELA enterprise value is higher than 50.59% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-3.51
TELA EV/EBITDA is -3.51

EV/EBITDA Sector Rank

28.03%
TELA EV/EBITDA is higher than 28.03% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

4.23
TELA annual current ratio is 4.23

Annual Quick Ratio

3.45
TELA annual quick ratio is 3.45

Leverage

Annual Debt To Equity

2.15
TELA annual debt to equity ratio is 2.15

Annual Interest Coverage Ratio

-7.93
TELA annual interest coverage ratio is -7.93

Risk & Stability

Piotroski F-Score

1
TELA piotroski f-score is 1

Altman Z-Score

-4.91
TELA altman z-score is -4.91

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$78.05 M
TELA annual total assets is $78.05 million

Annual Non Current Assets

$6.32 M
TELA annual long term assets is $6.32 million

Annual Current Assets

$71.73 M
TELA annual total current assets is $71.73 million

Annual Cash & Cash Equivalents

$46.73 M
TELA annual cash & cash equivalents is $46.73 million

Equity

Annual Book Value

$18.88 M
TELA annual book value is $18.88 million

Annual Working Capital

$54.76 M
TELA annual working capital is $54.76 million

Liabilities

Annual Total Liabilities

$59.17 M
TELA annual total liabilities is $59.17 million

Annual Total Long Term Liabilities

$42.20 M
TELA annual total long term liabilities is $42.20 million

Annual Current Liabilities

$16.97 M
TELA annual total current liabilities is $16.97 million

Annual Accounts Payable

$1.67 M
TELA annual accounts payable is $1.67 million

Debt

Annual Total Debt

$41.08 M
TELA annual total debt is $41.08 million

Annual Total Debt 1-Year Change

+2.05%
TELA annual total debt is up +2.05% year-on-year

Annual Long Term Debt

$40.52 M
TELA annual long term debt is $40.52 million

Annual Short Term Debt

$565.00 K
TELA annual short term debt is $565.00 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$102.53 M
TELA annual total expenses is $102.53 million

Annual Operating Expenses

$84.19 M
TELA annual total operating expenses is $84.19 million

Annual Cost Of Goods Sold

$18.34 M
TELA annual cost of goods sold is $18.34 million

Annual SGA

$74.57 M
TELA annual SGA is $74.57 million

Annual D&A

$808.00 K
TELA annual depreciation & amortization is $808.00 thousand

Annual Interest Expense

$5.22 M
TELA annual interest expense is $5.22 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$40.86 M
TELA annual cash flow from operations is -$40.86 million

Annual CFO 1-Year Change

-0.27%
TELA annual cash flow from operations is down -0.27% year-on-year

Annual CFI

-$599.00 K
TELA annual cash flow from investing activities is -$599.00 thousand

Annual CFI 1-Year Change

+68%
TELA annual cash flow from investing activities is up +68% year-on-year

Annual CFF

$46.27 M
TELA annual cash flow from financing activities is $46.27 million

Annual CFF 1-Year Change

+13.26%
TELA annual cash flow from financing activities is up +13.26% year-on-year

Free CashFlow

Annual FCF

-$41.47 M
TELA annual free cash flow is -$41.47 million

Annual FCF 1-Year Change

+2.7%
TELA annual free cash flow is up +2.7% year-on-year

CAPEX

Annual CAPEX

$611.00 K
TELA annual capital expenditures is $611.00 thousand

Annual CAPEX 1-Year Change

-67.36%
TELA annual capital expenditures is down -67.36% year-on-year

Institutional Ownership

Similar stocks

VIGL logo
Vigil Neuroscience (VIGL)
SY logo
So-Young International (SY)
BNOX logo
Bionomics Limited (BNOX)
Baird Medical Investment Holdings Limited (BDMD)
BMEA logo
Biomea Fusion (BMEA)
ANIX logo
Anixa Biosciences (ANIX)
IMUX logo
Immunic (IMUX)
ACHV logo
Achieve Life Sciences (ACHV)
Lexeo Therapeutics (LXEO)

FAQ

  • What is the ticker symbol for TELA Bio?
  • Does TELA Bio pay dividends?
  • What sector is TELA Bio in?
  • What industry is TELA Bio in?
  • What country is TELA Bio based in?
  • When did TELA Bio go public?
  • Is TELA Bio in the S&P 500?
  • Is TELA Bio in the NASDAQ 100?
  • Is TELA Bio in the Dow Jones?
  • When was TELA Bio's last earnings report?
  • When does TELA Bio report earnings?
  • Should I buy TELA Bio stock now?

What is the ticker symbol for TELA Bio?

The ticker symbol for TELA Bio is NASDAQ:TELA

Does TELA Bio pay dividends?

No, TELA Bio does not pay dividends

What sector is TELA Bio in?

TELA Bio is in the Healthcare sector

What industry is TELA Bio in?

TELA Bio is in the Medical Devices industry

What country is TELA Bio based in?

TELA Bio is headquartered in United States

When did TELA Bio go public?

TELA Bio's initial public offering (IPO) was on November 8, 2019

Is TELA Bio in the S&P 500?

No, TELA Bio is not included in the S&P 500 index

Is TELA Bio in the NASDAQ 100?

No, TELA Bio is not included in the NASDAQ 100 index

Is TELA Bio in the Dow Jones?

No, TELA Bio is not included in the Dow Jones index

When was TELA Bio's last earnings report?

TELA Bio's most recent earnings report was on Nov 7, 2024

When does TELA Bio report earnings?

The next expected earnings date for TELA Bio is Mar 21, 2025

Should I buy TELA Bio stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions